We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Next Generation of Rapid Diagnostic Assays Will Combine Disposable Test Materials with Smartphone Applications

By LabMedica International staff writers
Posted on 26 Apr 2015
Print article
Image: Thin, lightweight, and flexible materials integrate cellulose paper and flexible polyester films as new diagnostic tools to detect biological agents in whole blood, serum, and peritoneal fluid (Photo courtesy of Florida Atlantic University).
Image: Thin, lightweight, and flexible materials integrate cellulose paper and flexible polyester films as new diagnostic tools to detect biological agents in whole blood, serum, and peritoneal fluid (Photo courtesy of Florida Atlantic University).
The new generation of rapid diagnostic tests will reflect advances in both materials sciences and instant communications via the Internet and social media.

Current diagnostic assays commonly require long assay time, sophisticated infrastructure, and expensive reagents that are not compatible with resource-constrained and geographically isolated settings. While paper and flexible material-based platform technologies provide alternative approaches for the development of point-of-care (POC) diagnostic assays for broad applications in medicine, they lack the capability of transferring test results to a central location.

Investigators at Florida Atlantic University (Boca Raton, USA), Stanford University (Palo Alto, CA, USA), and Harvard University (Cambridge, MA, USA) have been working to integrate cellulose paper and flexible polyester film-based assays with dedicated smartphone applications.

In a recently published paper, the investigators presented a snapshot of the current state of the art. They described the use of three different paper and flexible material-based platforms with embedded electrical and optical sensing modalities to develop tests for the selective and accurate capture and detection of multiple biological targets. Finger prick volume equivalents of biological specimens such as whole blood, plasma, and peritoneal dialysis effluent were tested. Viruses (Human immunodeficieny virus 1), bacteria (Escherichia coli and Staphylococcus aureus), and cells (CD4+ T lymphocytes) were identified with clinically relevant levels of detection and sensitivity. A smartphone application was developed that allowed images of the test results to be sent from a cellular telephone for analysis anywhere in the world.

"The future of diagnostics and health monitoring will have potentially cell-phone based or portable readers sipping saliva or blood and continuously monitoring human health taking it way beyond where we are with counting steps today," said senior author Dr. Uktan Demirci, associate professor of radiology at Stanford University.

The paper was published in the March 6, 2015, online edition of the journal Nature Scientific Reports.

Related Links:

Florida Atlantic University
Stanford University
Harvard University


Gold Member
Hematology Analyzer
Swelab Lumi
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Herpes Virus Test
Human Herpes Virus (HHV-6) Real Time PCR Kit
New
Vitamin B12 Test
CHORUS CLIA VIT B12

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.